$PDLI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PDL BIOPHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PDL BIOPHARMA, INC.. Get notifications about new insider transactions in PDL BIOPHARMA, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 28 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.13 | 365 | 8,442 | 727 | 1.1 K to 727 (-33.42 %) |
Nov 28 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.09 | 365 | 8,428 | 1,092 | 1.5 K to 1.1 K (-25.05 %) |
Nov 28 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 22.84 | 365 | 8,337 | 1,457 | 1.8 K to 1.5 K (-20.03 %) |
Nov 28 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 22.46 | 365 | 8,198 | 1,822 | 2.2 K to 1.8 K (-16.69 %) |
Nov 28 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 15.73 | 2,187 | 34,402 | 2,187 | 0 to 2.2 K |
Nov 16 2006 | PDLI | PDL BIOPHARMA, INC ... | JUE GEORGE | VP of Finance | Option Exercise | M | 15.73 | 9,200 | 144,716 | 63,441 | |
Nov 16 2006 | PDLI | PDL BIOPHARMA, INC ... | JUE GEORGE | VP of Finance | Sell | S | 21.55 | 2,000 | 43,100 | 1,060 | 3.1 K to 1.1 K (-65.36 %) |
Nov 16 2006 | PDLI | PDL BIOPHARMA, INC ... | JUE GEORGE | VP of Finance | Sell | S | 21.40 | 2,000 | 42,800 | 3,060 | 5.1 K to 3.1 K (-39.53 %) |
Nov 16 2006 | PDLI | PDL BIOPHARMA, INC ... | JUE GEORGE | VP of Finance | Sell | S | 21.28 | 2,000 | 42,560 | 5,060 | 7.1 K to 5.1 K (-28.33 %) |
Nov 16 2006 | PDLI | PDL BIOPHARMA, INC ... | JUE GEORGE | VP of Finance | Sell | S | 21.50 | 2,000 | 43,000 | 7,060 | 9.1 K to 7.1 K (-22.08 %) |
Nov 16 2006 | PDLI | PDL BIOPHARMA, INC ... | JUE GEORGE | VP of Finance | Sell | S | 22.55 | 1,200 | 27,060 | 9,060 | 10.3 K to 9.1 K (-11.70 %) |
Nov 16 2006 | PDLI | PDL BIOPHARMA, INC ... | JUE GEORGE | VP of Finance | Buy | M | 15.73 | 9,200 | 144,716 | 10,260 | 1.1 K to 10.3 K (+867.92 %) |
Nov 16 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 17.13 | 1,935 | 33,147 | 29,065 | |
Nov 16 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 22.00 | 1,935 | 42,570 | 0 | 1.9 K to 0 (-100.00 %) |
Nov 16 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 17.13 | 1,935 | 33,147 | 1,935 | 0 to 1.9 K |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Option Exercise | M | 13.29 | 13,125 | 174,431 | 30,625 | |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.22 | 700 | 14,154 | 24,382 | 25.1 K to 24.4 K (-2.79 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.21 | 100 | 2,021 | 25,082 | 25.2 K to 25.1 K (-0.40 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.20 | 500 | 10,100 | 25,182 | 25.7 K to 25.2 K (-1.95 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.17 | 400 | 8,068 | 25,682 | 26.1 K to 25.7 K (-1.53 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.16 | 100 | 2,016 | 26,082 | 26.2 K to 26.1 K (-0.38 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.15 | 100 | 2,015 | 26,182 | 26.3 K to 26.2 K (-0.38 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.13 | 100 | 2,013 | 26,282 | 26.4 K to 26.3 K (-0.38 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.12 | 400 | 8,048 | 26,382 | 26.8 K to 26.4 K (-1.49 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.11 | 2,100 | 42,231 | 26,782 | 28.9 K to 26.8 K (-7.27 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.10 | 600 | 12,060 | 28,882 | 29.5 K to 28.9 K (-2.04 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.09 | 700 | 14,063 | 29,482 | 30.2 K to 29.5 K (-2.32 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.08 | 800 | 16,064 | 30,182 | 31 K to 30.2 K (-2.58 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.07 | 100 | 2,007 | 30,982 | 31.1 K to 31 K (-0.32 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.06 | 100 | 2,006 | 31,082 | 31.2 K to 31.1 K (-0.32 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.05 | 200 | 4,010 | 31,182 | 31.4 K to 31.2 K (-0.64 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.04 | 300 | 6,012 | 31,382 | 31.7 K to 31.4 K (-0.95 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.03 | 32 | 641 | 31,682 | 31.7 K to 31.7 K (-0.10 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.02 | 500 | 10,010 | 31,714 | 32.2 K to 31.7 K (-1.55 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.01 | 100 | 2,001 | 32,214 | 32.3 K to 32.2 K (-0.31 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 20.00 | 515 | 10,300 | 32,314 | 32.8 K to 32.3 K (-1.57 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 19.99 | 3,800 | 75,962 | 32,829 | 36.6 K to 32.8 K (-10.37 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 19.98 | 198 | 3,956 | 36,629 | 36.8 K to 36.6 K (-0.54 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 19.97 | 680 | 13,580 | 36,827 | 37.5 K to 36.8 K (-1.81 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Buy | M | 13.29 | 13,125 | 174,431 | 37,507 | 24.4 K to 37.5 K (+53.83 %) |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | M | 6.63 | 40,000 | 265,000 | 0 | |
Nov 08 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Buy | M | 6.63 | 40,000 | 265,000 | 141,680 | 101.7 K to 141.7 K (+39.34 %) |
Oct 26 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 15.73 | 2,187 | 34,402 | 63,441 | |
Oct 26 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.36 | 2,187 | 44,527 | 0 | 2.2 K to 0 (-100.00 %) |
Oct 26 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 15.73 | 2,187 | 34,402 | 2,187 | 0 to 2.2 K |
Oct 12 2006 | PDLI | PDL BIOPHARMA, INC ... | Calcott Peter H | VP, Quality & Comp ... | Sell | S | 20.34 | 625 | 12,713 | 1,875 | 2.5 K to 1.9 K (-25.00 %) |
Oct 10 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 15.73 | 8,748 | 137,606 | 65,628 | |
Oct 10 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.00 | 8,748 | 174,960 | 0 | 8.7 K to 0 (-100.00 %) |
Oct 10 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 15.73 | 8,748 | 137,606 | 8,748 | 0 to 8.7 K |
Jul 24 2006 | PDLI | PDL BIOPHARMA, INC ... | JUE GEORGE | VP, Fin & Corp. Co ... | Option Exercise | A | 17.13 | 17,500 | 299,775 | 17,500 | |
Jul 24 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | A | 17.13 | 31,000 | 531,030 | 31,000 | |
Jul 24 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Option Exercise | A | 17.13 | 19,500 | 334,035 | 19,500 | |
Jul 24 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Grant | A | 0.00 | 13,000 | 0 | 24,382 | 11.4 K to 24.4 K (+114.22 %) |
Jul 24 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | SVP & CSO | Option Exercise | A | 17.13 | 25,500 | 436,815 | 25,500 | |
Jul 24 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | SVP & CSO | Grant | A | 0.00 | 17,000 | 0 | 54,572 | 37.6 K to 54.6 K (+45.25 %) |
Jul 24 2006 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SVP Mktg & Busines ... | Option Exercise | A | 17.13 | 18,750 | 321,188 | 18,750 | |
Jul 24 2006 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SVP Mktg & Busines ... | Grant | A | 0.00 | 12,500 | 0 | 13,940 | 1.4 K to 13.9 K (+868.06 %) |
Jul 24 2006 | PDLI | PDL BIOPHARMA, INC ... | GUGGENHIME ANDREW | SVP & Chief Financ ... | Option Exercise | A | 17.13 | 20,000 | 342,600 | 20,000 | |
Jul 24 2006 | PDLI | PDL BIOPHARMA, INC ... | BENNER STEVEN E | SVP & Chief Med. O ... | Option Exercise | A | 17.13 | 10,500 | 179,865 | 10,500 | |
Jul 24 2006 | PDLI | PDL BIOPHARMA, INC ... | BENNER STEVEN E | SVP & Chief Med. O ... | Grant | A | 0.00 | 7,000 | 0 | 17,927 | 10.9 K to 17.9 K (+64.06 %) |
Jul 24 2006 | PDLI | PDL BIOPHARMA, INC ... | Calcott Peter H | VP, Quality & Comp ... | Option Exercise | A | 17.13 | 21,000 | 359,730 | 21,000 | |
Jul 21 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | M | 6.63 | 30,000 | 198,750 | 40,000 | |
Jul 21 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Buy | M | 6.63 | 30,000 | 198,750 | 101,680 | 71.7 K to 101.7 K (+41.85 %) |
Jul 18 2006 | PDLI | PDL BIOPHARMA, INC ... | BENNER STEVEN E | SVP & Chief Med. O ... | Payment of Exercise | F | 17.40 | 1,073 | 18,670 | 10,927 | 12 K to 10.9 K (-8.94 %) |
Jul 17 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Payment of Exercise | F | 17.40 | 1,118 | 19,453 | 11,382 | 12.5 K to 11.4 K (-8.94 %) |
Jul 17 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Payment of Exercise | F | 17.40 | 1,448 | 25,195 | 37,572 | 39 K to 37.6 K (-3.71 %) |
Jul 17 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Payment of Exercise | F | 17.40 | 6,863 | 119,416 | 53,137 | 60 K to 53.1 K (-11.44 %) |
Jul 07 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 18.56 | 315 | 5,847 | 0 | 315 to 0 (-100.00 %) |
Jul 07 2006 | PDLI | PDL BIOPHARMA, INC ... | Calcott Peter H | VP, Quality & Comp ... | Sell | S | 18.44 | 439 | 8,095 | 2,500 | 2.9 K to 2.5 K (-14.94 %) |
Jun 16 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Option Exercise | A | 17.29 | 6,250 | 108,063 | 6,250 | |
Jun 16 2006 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 17.29 | 3,000 | 51,870 | 3,000 | |
Jun 16 2006 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 17.29 | 3,000 | 51,870 | 3,000 | |
Jun 16 2006 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 17.29 | 3,000 | 51,870 | 3,000 | |
Jun 16 2006 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 17.29 | 3,000 | 51,870 | 3,000 | |
Jun 16 2006 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 17.29 | 15,000 | 259,350 | 15,000 | |
Jun 16 2006 | PDLI | PDL BIOPHARMA, INC ... | Goodwin Bradford S | Director | Option Exercise | A | 17.29 | 1,250 | 21,613 | 1,250 | |
Jun 15 2006 | PDLI | PDL BIOPHARMA, INC ... | Broder Samuel | Director | Option Exercise | A | 17.29 | 3,000 | 51,870 | 3,000 | |
Jun 15 2006 | PDLI | PDL BIOPHARMA, INC ... | Broder Samuel | Director | Option Exercise | A | 17.29 | 3,000 | 51,870 | 3,000 | |
Jun 15 2006 | PDLI | PDL BIOPHARMA, INC ... | Broder Samuel | Director | Option Exercise | A | 17.29 | 10,000 | 172,900 | 10,000 | |
Jun 15 2006 | PDLI | PDL BIOPHARMA, INC ... | GAGE L PATRICK | Director | Option Exercise | A | 17.29 | 3,000 | 51,870 | 3,000 | |
Jun 15 2006 | PDLI | PDL BIOPHARMA, INC ... | GAGE L PATRICK | Director | Option Exercise | A | 17.29 | 3,000 | 51,870 | 3,000 | |
Jun 15 2006 | PDLI | PDL BIOPHARMA, INC ... | GAGE L PATRICK | Director | Option Exercise | A | 17.29 | 15,000 | 259,350 | 15,000 | |
Jun 15 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | A | 17.29 | 3,000 | 51,870 | 3,000 | |
Jun 15 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | A | 17.29 | 3,000 | 51,870 | 3,000 | |
Jun 15 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | A | 17.29 | 15,000 | 259,350 | 15,000 | |
Jun 15 2006 | PDLI | PDL BIOPHARMA, INC ... | LINK MAX | Director | Option Exercise | A | 17.29 | 3,000 | 51,870 | 3,000 | |
Jun 15 2006 | PDLI | PDL BIOPHARMA, INC ... | LINK MAX | Director | Option Exercise | A | 17.29 | 3,000 | 51,870 | 3,000 | |
Jun 15 2006 | PDLI | PDL BIOPHARMA, INC ... | LINK MAX | Director | Option Exercise | A | 17.29 | 3,000 | 51,870 | 3,000 | |
Jun 15 2006 | PDLI | PDL BIOPHARMA, INC ... | LINK MAX | Director | Option Exercise | A | 17.29 | 25,000 | 432,250 | 25,000 | |
Jun 15 2006 | PDLI | PDL BIOPHARMA, INC ... | LINK MAX | Director | Option Exercise | A | 17.29 | 15,000 | 259,350 | 15,000 | |
Jun 01 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | M | 6.63 | 30,000 | 198,750 | 70,000 | |
Jun 01 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Buy | M | 6.63 | 30,000 | 198,750 | 71,680 | 41.7 K to 71.7 K (+71.98 %) |
Apr 26 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales O ... | Option Exercise | M | 15.73 | 2,187 | 34,402 | 76,563 | |
Apr 26 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales O ... | Sell | S | 28.90 | 2,187 | 63,198 | 0 | 2.2 K to 0 (-100.00 %) |
Apr 26 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales O ... | Buy | M | 15.73 | 2,187 | 34,402 | 2,187 | 0 to 2.2 K |
May 05 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | M | 6.63 | 40,000 | 265,000 | 100,000 | |
May 05 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Buy | M | 6.63 | 40,000 | 265,000 | 41,680 | 1.7 K to 41.7 K (+2,380.95 %) |
May 30 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 15.73 | 2,187 | 34,402 | 74,376 | |
May 30 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.00 | 2,187 | 43,740 | 0 | 2.2 K to 0 (-100.00 %) |
May 30 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 15.73 | 2,187 | 34,402 | 2,187 | 0 to 2.2 K |
Apr 24 2006 | PDLI | PDL BIOPHARMA, INC ... | Goodwin Bradford S | Director | Option Exercise | A | 29.80 | 15,000 | 447,000 | 15,000 | |
Apr 20 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 30.01 | 5,000 | 150,046 | 1,680 | 6.7 K to 1.7 K (-74.85 %) |
Apr 12 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 30.58 | 5,000 | 152,912 | 6,680 | 11.7 K to 6.7 K (-42.81 %) |
Apr 06 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Option Exercise | M | 13.29 | 2,188 | 29,079 | 43,750 | |
Apr 06 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 32.16 | 2,188 | 70,366 | 12,500 | 14.7 K to 12.5 K (-14.90 %) |
Apr 06 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Buy | M | 13.29 | 2,188 | 29,079 | 14,688 | 12.5 K to 14.7 K (+17.50 %) |
Apr 05 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 32.77 | 5,000 | 163,844 | 11,680 | 16.7 K to 11.7 K (-29.98 %) |
Apr 05 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 32.79 | 5,000 | 163,954 | 16,680 | 21.7 K to 16.7 K (-23.06 %) |
Apr 05 2006 | PDLI | PDL BIOPHARMA, INC ... | GUGGENHIME ANDREW | SVP & Chief Financi ... | Option Exercise | A | 32.49 | 65,000 | 2,111,850 | 65,000 | |
Apr 05 2006 | PDLI | PDL BIOPHARMA, INC ... | GUGGENHIME ANDREW | SVP & Chief Financi ... | Grant | A | 32.49 | 7,500 | 243,675 | 7,500 | 0 to 7.5 K |
Jan 19 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 600,000 | |
Jan 19 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 28.02 | 10,000 | 280,210 | 60,000 | 70 K to 60 K (-14.29 %) |
Jan 19 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 70,000 | 60 K to 70 K (+16.67 %) |
Jan 17 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 610,000 | |
Jan 17 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 28.29 | 10,000 | 282,900 | 60,000 | 70 K to 60 K (-14.29 %) |
Jan 17 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 70,000 | 60 K to 70 K (+16.67 %) |
Jan 17 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 620,000 | |
Jan 17 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 29.26 | 10,000 | 292,600 | 60,000 | 70 K to 60 K (-14.29 %) |
Jan 17 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 70,000 | 60 K to 70 K (+16.67 %) |
Jan 13 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 630,000 | |
Jan 13 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 29.93 | 10,000 | 299,320 | 60,000 | 70 K to 60 K (-14.29 %) |
Jan 13 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 70,000 | 60 K to 70 K (+16.67 %) |
Jan 12 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 640,000 | |
Jan 12 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 31.29 | 10,000 | 312,900 | 60,000 | 70 K to 60 K (-14.29 %) |
Jan 12 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 70,000 | 60 K to 70 K (+16.67 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 31.35 | 1,600 | 50,160 | 353,178 | 354.8 K to 353.2 K (-0.45 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 31.34 | 1,836 | 57,540 | 354,778 | 356.6 K to 354.8 K (-0.51 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 31.33 | 400 | 12,532 | 356,614 | 357 K to 356.6 K (-0.11 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 31.32 | 4,121 | 129,070 | 357,014 | 361.1 K to 357 K (-1.14 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 31.31 | 3,105 | 97,218 | 361,135 | 364.2 K to 361.1 K (-0.85 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 31.30 | 23,938 | 749,259 | 364,240 | 388.2 K to 364.2 K (-6.17 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 30.92 | 100 | 3,092 | 388,178 | 388.3 K to 388.2 K (-0.03 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 30.87 | 1,400 | 43,218 | 388,278 | 389.7 K to 388.3 K (-0.36 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 30.86 | 500 | 15,430 | 389,678 | 390.2 K to 389.7 K (-0.13 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 30.85 | 2,100 | 64,785 | 390,178 | 392.3 K to 390.2 K (-0.54 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 30.84 | 3,300 | 101,772 | 392,278 | 395.6 K to 392.3 K (-0.83 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 30.83 | 600 | 18,498 | 395,578 | 396.2 K to 395.6 K (-0.15 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 30.82 | 1,150 | 35,443 | 396,178 | 397.3 K to 396.2 K (-0.29 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 30.81 | 1,917 | 59,063 | 397,328 | 399.2 K to 397.3 K (-0.48 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 30.80 | 23,933 | 737,136 | 399,245 | 423.2 K to 399.2 K (-5.66 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 31.17 | 1,000 | 31,170 | 76,680 | 77.7 K to 76.7 K (-1.29 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 30.59 | 5,000 | 152,958 | 77,680 | 82.7 K to 77.7 K (-6.05 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SVP Marketing&Busin ... | Option Exercise | M | 12.29 | 5,000 | 61,450 | 5,000 | |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SVP Marketing&Busin ... | Sell | S | 31.00 | 5,000 | 155,000 | 1,001 | 6 K to 1 K (-83.32 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | SHAH JAISIM | SVP Marketing&Busin ... | Buy | M | 12.29 | 5,000 | 61,450 | 6,001 | 1 K to 6 K (+499.50 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 650,000 | |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 30.51 | 10,000 | 305,100 | 60,000 | 70 K to 60 K (-14.29 %) |
Jan 11 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 70,000 | 60 K to 70 K (+16.67 %) |
Jan 10 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 660,000 | |
Jan 10 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 30.10 | 10,000 | 301,000 | 60,000 | 70 K to 60 K (-14.29 %) |